{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:56:09Z","timestamp":1794725769643,"version":"4.9.1"},"reference-count":47,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The most common cutaneous T\u2010cell lymphomas (CTCLs) are mycosis fungoides and S\u00e9zary syndrome.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To determine whether blood stage and other prognostic variables affect overall survival (OS) in CTCL.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> We studied retrospectively 1197 CTCL patients seen at the M.D. Anderson Cancer Center since 1987.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We identified 124 (10.3%) patients with erythrodermic CTCL (E\u2010CTCL), 63% of whom had positive gene rearrangements in skin and 19 of whom had no evidence of hematologic involvement. The median age at diagnosis was 63\u00a0years (range, 26\u201390\u00a0years); the male to female ratio was 1.3\u00a0:\u00a01. OS curves were estimated by the Kaplan\u2013Meier method and compared using log\u2010rank tests. The median OS in all 124 E\u2010CTCL patients was 5.1\u00a0years (range, 0.4\u201318.6\u00a0years) regardless of the cause of death or blood involvement. Patients were stratified by the H0\u2013H4 staging system with manual or flow cytometric determination of S\u00e9zary cell counts (Russell\u2010Jones R, Whittaker SJ. S\u00e9zary syndrome: diagnostic criteria and therapeutic options. <jats:italic>Semin Cutan Med Surg<\/jats:italic> 2000; <jats:bold>19<\/jats:bold>: 100\u2013108). The median OS was 7.6\u00a0years for H0\u2013H2 (&lt;\u00a01000 S\u00e9zary cells\/L) (<jats:italic>n<\/jats:italic>\u00a0=\u00a023), 5.4\u00a0years for H3 (\u2265\u00a01000 to \u2264\u00a010,000 S\u00e9zary cells\/L) (<jats:italic>n<\/jats:italic>\u00a0=\u00a079), and 2.4\u00a0years for H4 (\u2265\u00a010,000 S\u00e9zary cells\/L) (<jats:italic>n<\/jats:italic>\u00a0=\u00a022) (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.011). Treatment with systemic steroids, age, serum lactate dehydrogenase, and white blood cell count \u2265\u00a020,000\u00a0\u00b5L were significant prognostic factors, but large cell transformation, T\u2010cell receptor gene rearrangement, tumor\u2013node\u2013metastasis stage, treatments, and CD4\u00a0:\u00a0CD8 ratio were not. In multivariate analysis, advanced age and elevated lactate dehydrogenase were the strongest predictors of a poor prognosis.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Serum LDH and age were the strongest predictive factors for OS in E\u2010CTCL.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2009.03771.x","type":"journal-article","created":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T02:24:08Z","timestamp":1235096648000},"page":"243-252","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Overall survival in erythrodermic cutaneous T\u2010cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T\u2010cell lymphoma"],"prefix":"10.1111","volume":"48","author":[{"given":"Kelley A.","family":"Vidulich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhshandra","family":"Talpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland L.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108585"},{"key":"e_1_2_6_4_2","first-page":"254","article-title":"Erythrodermie avec pr\u00e9sence de cellules monstrueuses dans le derme et le sang circulant","volume":"45","author":"S\u00e9zary A","year":"1938","journal-title":"Bull Soc Fr Derm Syph"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.118538"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(03)00120-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.624"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810601)47:11<2671::AID-CNCR2820471125>3.0.CO;2-X"},{"key":"e_1_2_6_10_2","first-page":"725","article-title":"Report of the Committee on Staging and Classification of Cutaneous T\u2010Cell Lymphomas","volume":"63","author":"Bunn PA","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-2-187"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-5-372"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.3.841.841"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.2.358.358"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70212-3"},{"key":"e_1_2_6_16_2","first-page":"519","article-title":"Clinical studies of T\u2010cell erythroderma in the S\u00e9zary syndrome","volume":"49","author":"Winkelmann RK","year":"1974","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.117.7.382"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archderm.1983.01650280013006","article-title":"Pre\u2010S\u00e9zary erythroderma evolving to S\u00e9zary syndrome. A report of seven cases","volume":"119","author":"Buechner SA","year":"1983","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600709655"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(00)80006-1"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70162-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1309\/YB79JG4TMJERQ7PV"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05677.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the S\u00e9zary syndrome","volume":"131","author":"Kim YH","year":"1995","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.4.504"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70491-3"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.857"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11780"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.9.1057"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290026367"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archderm.1991.01680090075007","article-title":"Prognostic clinicopathological factors in cutaneous T\u2010cell lymphoma","volume":"127","author":"Marti RM","year":"1991","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199910000-00019"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2001.028008412.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01476.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-2-5"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04014.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.1.32"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.287"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90496-X"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690020064010"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480100060031"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890415)63:8<1612::AID-CNCR2820630828>3.0.CO;2-C"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.11.1381"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06676.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000054652"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008397323199"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2009.03771.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2009.03771.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:24:44Z","timestamp":1696955084000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2009.03771.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1365-4632.2009.03771.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.03771.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]},"assertion":[{"value":"2009-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}